Cargando…
A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by damage to the alveolar epithelium, leading to fibrosis and excessive accumulation of extracellular matrix in the interstitium of the lung. In the present study we performed high-resolution proteom...
Autores principales: | Sikkeland, Liv I. B., Ueland, Thor, Lund, May B., Durheim, Michael Thomas, Mollnes, Tom Eirik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444977/ https://www.ncbi.nlm.nih.gov/pubmed/37621463 http://dx.doi.org/10.3389/fmed.2023.1236495 |
Ejemplares similares
-
Comparison of different reference values for lung function: implications of inconsistent use among centers
por: Mangseth, Henrik, et al.
Publicado: (2023) -
The alternative complement pathway revisited
por: Harboe, Morten, et al.
Publicado: (2008) -
The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
por: Holt, Margrethe Flesvig, et al.
Publicado: (2021) -
The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017) -
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017)